How to Help Your Patients Find Marplan in Stock: A Provider's Guide

Updated:

February 15, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A practical guide for providers to help patients locate Marplan (Isocarboxazid) during the ongoing shortage. Steps, tools, and alternative strategies.

Your Patients Need Marplan — Here's How to Help Them Get It

As a prescriber, you've done the clinical work: evaluated your patient, tried first-line treatments, and determined that Marplan (Isocarboxazid) is the right medication. But in 2026, writing the prescription is only half the battle. Your patient now has to actually find a pharmacy that has it in stock — and for a sole-source, brand-only MAOI with ongoing supply issues, that's far from guaranteed.

This guide gives you concrete, actionable steps to help your patients find and maintain access to Marplan.

Current Availability Landscape

Marplan's availability in 2026 can be described as intermittent and unpredictable:

  • No generic exists: Isocarboxazid is available only as brand-name Marplan from Validus Pharmaceuticals LLC
  • Chain pharmacies rarely stock it: CVS, Walgreens, and similar chains typically don't carry Marplan unless a patient has specifically requested it
  • Wholesaler availability fluctuates: Even when pharmacies try to order Marplan, their primary wholesaler may not have it
  • FDA importation: Validus has coordinated with the FDA to temporarily import Marplan to address critical shortages

For the most current picture, check Medfinder for Providers.

Why Patients Can't Find Marplan

Understanding the supply chain helps you counsel patients more effectively:

  1. Sole-source manufacturing: One manufacturer means zero redundancy. Any production issue halts the entire supply.
  2. Economic disincentive: With a small patient population, there's limited commercial motivation for large production runs or generic development.
  3. Pharmacy ordering behavior: Most pharmacies use automated ordering systems that only restock drugs with recent sales history. If no one has filled Marplan recently, the system won't order it.
  4. Wholesaler allocation: During shortages, wholesalers may allocate limited supply to pharmacies with established ordering history for the product.

5 Steps to Help Your Patients

Step 1: Verify Availability Before the Patient Leaves

Before your patient walks out the door with a new prescription, take 60 seconds to check availability. Use Medfinder for Providers to see which pharmacies near the patient currently have Marplan in stock. This single step can save your patient days of frustration and phone calls.

If Marplan isn't available nearby, you can adjust the plan in real time — either choosing a pharmacy in a broader radius or discussing an alternative medication before the patient has a failed fill attempt.

Step 2: Send the Prescription to the Right Pharmacy

Once you've identified a pharmacy with Marplan in stock, send the prescription directly there. Avoid sending it to the patient's "usual" pharmacy if that pharmacy doesn't carry Marplan — this creates unnecessary delays and transfers.

If the patient's insurance requires a specific pharmacy network, work with the patient to identify an in-network pharmacy that has stock.

Step 3: Prescribe 90-Day Supplies When Possible

When Marplan is available, maximizing the supply duration reduces the frequency of the search process. If the patient's insurance and state regulations allow it, prescribe a 90-day supply. This gives the patient a 3-month buffer and reduces the risk of a gap in therapy.

Even if insurance only covers 30-day fills, discuss with the patient whether paying cash for a 90-day supply might be worth the peace of mind — particularly if they've had difficulty finding Marplan before.

Step 4: Build Relationships with Specialty Pharmacies

Identify 2-3 independent or specialty pharmacies in your area that reliably source hard-to-find medications. Over time, building a relationship with these pharmacies benefits all of your patients on niche medications — not just those on Marplan.

Some specialty pharmacies will proactively notify your office when supply of a specific medication becomes available or runs low.

Step 5: Have a Contingency Plan Ready

For every patient on Marplan, document a backup medication plan in the chart. This should include:

  • Which alternative MAOI you would switch to (Nardil, Parnate, or Emsam) and at what dose
  • The washout period required if switching to a non-MAOI
  • Patient preferences and any prior medication trials

Having this plan documented means you can act quickly if supply is interrupted, rather than starting the clinical decision-making process from scratch under time pressure.

Alternative MAOIs to Consider

When Marplan is unavailable, the three primary MAOI alternatives are:

  • Nardil (Phenelzine): Closest pharmacological match — same hydrazine subclass, same mechanism. Typical dose 45-90 mg/day. Note: Nardil has also experienced supply issues.
  • Parnate (Tranylcypromine): Non-hydrazine MAOI. More activating profile. Typical dose 30-60 mg/day. Generally more available than Marplan.
  • Emsam (Selegiline patch): Transdermal delivery. No dietary restrictions at 6 mg/24 hr dose. May be less potent for severe treatment-resistant depression. More expensive.

For a patient-facing comparison, share our article on alternatives to Marplan.

Workflow Tips for Your Practice

  • Flag Marplan patients in your EHR: Create a patient list or flag for everyone currently on Marplan so you can proactively monitor their refill status.
  • Assign a staff member to check supply: Designate someone in your office to periodically check Marplan availability via Medfinder and proactively contact patients when supply appears.
  • Coordinate with the manufacturer: Validus Pharmaceuticals can be reached at 1-866-982-5438 for supply inquiries. They may be able to direct you to pharmacies with current stock.
  • Document shortage-related switches: When a patient must switch medications due to supply issues (not clinical failure), document the reason clearly. This helps with insurance appeals if the patient needs to switch back when Marplan becomes available.
  • Share cost resources: Point patients to the Marplan co-pay card (as low as $20/month for commercially insured patients) and patient assistance programs like Prescription Hope ($70/month). More details in our provider's guide to saving patients money on Marplan.

Final Thoughts

The Marplan shortage is a structural problem that won't resolve overnight. But providers who are proactive — verifying stock before prescribing, building pharmacy relationships, maintaining contingency plans, and leveraging tools like Medfinder for Providers — can significantly reduce the burden on their patients.

For the clinical perspective on the shortage itself, see our provider shortage briefing. For patient-facing resources you can share, check out How to find Marplan in stock near you.

What's the most efficient way for providers to check Marplan availability?

Use Medfinder for Providers (medfinder.com/providers) to check real-time pharmacy availability in your patient's area. This is faster than having patients call multiple pharmacies and allows you to direct prescriptions to pharmacies that actually have stock.

Should I avoid starting new patients on Marplan given the shortage?

Not necessarily. If Marplan is clinically indicated and other MAOIs are less suitable, it may still be the right choice. However, verify availability before prescribing and ensure the patient understands the supply challenges. Having a documented contingency plan is essential for all patients on Marplan.

How should I handle insurance prior authorization for Marplan?

Most insurers require prior authorization for Marplan and evidence of inadequate response to first-line agents (SSRIs, SNRIs). Document failed trials thoroughly. If an insurer denies coverage, peer-to-peer review may help. The Marplan co-pay card can offset costs for commercially insured patients while PA is processed.

Can I prescribe Marplan via telehealth?

While MAOIs can technically be prescribed via telehealth where state regulations allow, the dietary restrictions, drug interaction profile, and monitoring requirements of Marplan typically favor in-person management, especially during initiation. Many psychiatrists prefer initial in-person evaluation with telehealth follow-up for stable patients.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
99% success rate
Fast-turnaround time
Never call another pharmacy